Production (Stage)
Caribou Biosciences, Inc.
CRBU
$1.20
$0.0786.96%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 3.01% | -2.85% | -246.77% | -27.70% | -47.03% |
| Total Depreciation and Amortization | 64.08% | 60.00% | -25.46% | 38.74% | 20.54% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -13.74% | -57.38% | 115.38% | -31.57% | 122.04% |
| Change in Net Operating Assets | -76.21% | -185.63% | 87.20% | -76.33% | 64.06% |
| Cash from Operations | 1.28% | -65.91% | -13.45% | -116.44% | -33.16% |
| Capital Expenditure | 28.04% | 77.25% | 85.84% | 12.22% | 28.71% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 106.62% | 156.29% | 142.67% | 72.15% | 7.35% |
| Cash from Investing | 115.11% | 150.61% | 138.73% | 91.61% | 10.88% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -96.25% | -- | -99.82% | -99.25% | 660.35% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -96.25% | 9,083.72% | -99.82% | -99.25% | 660.35% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 844.84% | 70.36% | -115.57% | -185.75% | 68.50% |